The effect of IL-1 receptor antagonist on the proliferation of hematopoietic progenitor cells in regenerating bone marrow

Leukemia

Volumn 10, Issue 3, 1996, Pages 564-569

  Jovcic G ^a   Ivanovic Z ^a   Biljanovic Paunovic L ^a   Bugarski, D ^a   Stosic Grujicic S ^b   Milenkovic P ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Hematopoietic progenitor cells; Regenerating bone marrow; RhIL 1ra

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; BURST FORMING UNIT E; CELL CYCLE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL REGENERATION; COLONY FORMING UNIT E; COLONY FORMING UNIT GM; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; IRRADIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING;

EID: 0029918336     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Dinarello CA. The biological properties of interleukin-1. Eur Cytokine Netw 1994; 5: 517-531.
2. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77: 1627-1652.
3. Bagby GC. Interleukin-1 and hematopoiesis. Blood Rev 1989; 3: 152-161.
4. Sims JE, Dower SK. Interleukin-1 receptors. Eur Cytokine Netw 1994; 5: 539-546.
5. Bomsztyk K, Sims JE, Stanton TH, Slack J, McMahan CJ, Valentine MA, Dower SK. Evidence for different interleukin 1 receptors in murine B- and T-cell lines. Proc Natl Acad Sci USA 1989; 86: 8034-8038.
6. Eisenberg SP, Evans RJ, Arend WP, Verderber E, Brewer T, Hannum CH, Thompson RC. Primary structure and functional expression from a complementary DNA of a human interleukin-1 receptor antagonist. Nature 1990; 343: 336-340.
7. Zahedi K, Seldin MF, Rits M, Ezekowitz AB, Whitehead AS. Mouse IL-1 receptor antagonist protein: molecular characterization, gene mapping, and expression of mRNA in vitro and in vivo. J Immunol 1991; 146: 4228-4233.
8. Goto F, Goto K, Miyamata T, Ohkawara S, Takao T, Mori S, Furukawa S, Maeda T, Iwanaga S, Shimonishi Y, Yoshinaga M. Interieukin-1 receptor antagonist in inflammatory exudate cells of rabbits. Production, purification and determination of primary structure. Immunology 1992; 77: 235-244.
9. Milenković P, Stošić-Grujičić, Ivanović Z, Lukić M. The effect of IL-1 receptor blockade on proliferative activity of haemopoietic stem cells in regenerating bone marrow. In: Guigon M er al (eds). The Negative Regulation of Hematopoiesis. Colloque INSERM/John Libbey Eurotext: London, 1993, p 49.
10. Sheridan JW, Metcalf D. A low-molecular weight factor in lung-conditioned medium stimulating granulocyte-monocyte formation in vitro. J Cell Physiol 1973; 81: 11-23.
11. Stojanović N, Jovčić G, Milenković P, Pavlović-Kentera V. The effect of serum containing granulocytic stimulating activity and colony stimulating activity on regenerating hemopoiesis in mice. Biomed Pharmacother 1988; 42: 473-482.
12. Iscove NN, Sieber F, Winterhalter KH. Erythroid colony formation in cultures of mouse and human bone marrow: analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose concanavalin A. J Cell Physiol 1974; 83: 309-316.
13. Biljanović-Paunović L, Milenković P, Kapa D, Pavlović-Kentera V. Regeneration of erythroid progenitor cells in polycythemic mice treated with cyclophosphamide. Exp Hematol 1985; 13: 67-73.
14. Tambourin PE, Wendling F, Gallien-Lartigue O, Huaulme D. Production of high levels of erythropoietin in mice. Biomedicine 1973; 19: 112-116.
15. Lange W, Brugger W, Rosenthal FM, Kanz L, Lindemann A. The role of cytokines in oncology. In: Murphy MJ Jr (ed). Concise Reviews in Clinical and Experimental Hematology. AlphaMed Press: Dayton, OH, 1992, pp 13-26.
16. Sachs L. The molecular control of haematopoiesis and leukaemia. Eur J Cancer 1994; 30A: 852-860.
17. Loeffler M, Wichmann H-E. Acute irradiation - a model analysis. In: Wichmann H-E, Loeffler M (eds). Mathematical Modeling of Cell Proliferation: Stem Cell Regulation in Hemopoiesis. CRC Press: Boca Raton, FL, 1985, pp 125-138.
18. Neta R, Oppenheim JJ, Schreiber RD, Chizzonite R, Ledney D, Macvitte TJ. Role of cytokines (interleukin-1, tumor necrosis factor and transforming growth factor β) in natural and lipopolysaccharide-enhanced radioresistance. J Exp Med 1991; 173: 1177-1182.
19. Granstein RD, Sander DN. Whole body exposure to ultraviolet radiation results in increased serum interleukin-1 activity in humans. Lymphokine Res 1987; 6: 187-193
20. Stork LC, Peterson VM, Rundus CH, Robinson WA. Interleukin-1 enhances murine granulopoiesis in vivo. Exp Hematol 1988; 16: 163-167.
21. Jenkins JK, Arend WP. Interleukin-1 receptor antagonist production in human monocytes is induced by IL-1α, IL-3, IL-4 and GM-CSF. Cytokine 1993; 5: 407-415.
22. Matyak M, Smith MF, Abel AA, Arend WP. Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1β. J Clun Immunol 1994; 14: 20-30.
23. Hestdal K, Ruscetti FW, Chizzonite R, Ortiz M, Cooya JM, Longo DL, Keller JR. Interleukin-1 (IL-1) directly and indirectly promotes hematopoietic cell growth through type I IL-1 receptor. Blood 1994; 84: 125-132.
24. Johnson CS, Keckler DJ, Topper MI, Braunschweiger PG, Furmanski P. In vivo hematopoietic effects of recombinant interleukin-1α in mice: stimulation of granulocytic, monocytic, megakaryocytic, and early erythroid progenitors, suppression of late-stage erythropoiesis, and reversal of erythroid suppression with erythropoietin. Blood 1989; 73: 678-683.
25. Furmanski P, Johnson CS. Macrophage control of normal and leukemic erythropoiesis: identification of the macrophage-derived erythroid suppressing activity as interleukin-1 and the mediator of its in vivo action as tumor necrosis factor. Blood 1990; 75: 2328-2334.
26. Aoki I, Homori M, Nakahara K, Higashi K, Ishikawa K. Effects of rhIL-1α, rhIL-1β, and rhIL-1 receptor antagonist on erythroid progenitors (CFU-E and BFU-E) in human bone marrow. Exp Hematol 1995; 23: 217-225.
27. Dalmau SR, Freitas CS, Tabak DG. Interleukin-1 and tumor necrosis factor-alpha as radio- and chemoprotectors of bone marrow. Bone Marrow Transplant 1993; 12: 551-563.